A20-mediated KEAP1 ubiquitination orchestrates hepatocyte ferroptosis to ameliorate autoimmune hepatitis
Authors:
Abstract
Background: Autoimmune hepatitis (AIH) is characterised by death of hepatocytes and chronic inflammation. Patients with deleterious variants in A20 are identified with AIH presentations and immune activation. However, it remains unclear how A20 dysregulation contributes to AIH pathogenesis. Objective: This study elucidates the role and mechanism of A20 in AIH progression and its therapeutic potential. Design: A20 expression was analysed in patient sample and AIH mouse model. A20 function was explored in mice with hepatocyte-specific A20 knockout and overactivation and wild type controls. Liver samples were assessed by histology, immunoblot and electron microscopy. Proteomics, mass spectrometry, co-immunoprecipitation and site‐specific mutation experiments were used to elucidate underlying mechanisms. AdipoRon was used to identify the effects of pharmacological induction of A20 on AIH. Results: A20 expression is reduced in livers of individuals with AIH. In experimental AIH, hepatocyte-specific A20 depletion aggravates hepatic inflammation and fibrosis, enhances ferroptosis of hepatocytes and increases sensitivity to ferroptosis inhibitors, while A20 overexpression ameliorates AIH pathology and reduces hepatocyte ferroptosis. Mechanistically, A20 is found to interact with KEAP1 and mediate its K48-linked polyubiquitination degradation, promoting NRF2 accumulation and nuclear translocation to enhance antioxidant and antiferroptosis effects. Pharmacological induction of A20 confers protective effects in AIH. The clinical correlation among A20, KEAP1, NRF2 and ferroptosis is validated in human AIH samples. Conclusions: Our findings elucidate a previously unrecognised A20-KEAP1-NRF2 axis that orchestrates hepatocyte ferroptosis in AIH. Targeting A20 may provide a promising therapeutic strategy for AIH.Keywords
Funding Information
- Shangrao Science and Technology Bureau Fund (2023AB006)
- Project of Tongji Hospital Scientific Research Foundation (2023B13)
- National Natural Science Foundation of China (81974071)
- National Natural Science Foundation of China (82200588)
- National Natural Science Foundation of China (82270558)
This publication has 48 references indexed in Scilit:
- The Complexity of Being A20: From Biological Functions to Genetic AssociationsJournal of Clinical Immunology, 2024
- Treating autoimmune hepatitis – More science, more progress, better therapyJournal of Hepatology, 2024
- Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitisJournal of Hepatology, 2023
- SUMOylation of the ubiquitin ligase component KEAP1 at K39 upregulates NRF2 and its target function in lung cancer cell proliferationJournal of Biological Chemistry, 2023
- FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3International Immunopharmacology, 2023
- A20 and Cell Death-driven InflammationTrends in Immunology, 2020
- Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stressFree Radical Biology and Medicine, 2020
- Characterization of ferroptosis in murine models of hemochromatosisHepatology, 2017
- A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation ResponsesInflammation, 2017
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015